Marshall Wace’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,221
| Closed | -$1.15K | – | 2922 |
|
|
2024
Q2 | $1.15K | Buy |
+38,221
| New | +$1.15K | ﹤0.01% | 2247 |
|
|
2023
Q3 | – | Sell |
-87,037
| Closed | -$1.07M | – | 2673 |
|
|
2023
Q2 | $1.07M | Sell |
87,037
-11,218
| -11% | -$138K | ﹤0.01% | 1350 |
|
|
2023
Q1 | $1.21M | Buy |
+98,255
| New | +$1.21M | ﹤0.01% | 1352 |
|
|
2021
Q3 | – | Sell |
-39,150
| Closed | -$250K | – | 3435 |
|
|
2021
Q2 | $250K | Sell |
39,150
-52,616
| -57% | -$336K | ﹤0.01% | 1883 |
|
|
2021
Q1 | $576K | Buy |
91,766
+35,918
| +64% | +$225K | ﹤0.01% | 1597 |
|
|
2020
Q4 | $385K | Buy |
+55,848
| New | +$385K | ﹤0.01% | 1454 |
|
|
2016
Q4 | – | Sell |
-35,288
| Closed | -$1.76M | – | 1228 |
|
|
2016
Q3 | $1.76M | Buy |
+35,288
| New | +$1.76M | 0.01% | 621 |
|
|
2015
Q4 | – | Sell |
-41,862
| Closed | -$2.8M | – | 1219 |
|
|
2015
Q3 | $2.8M | Sell |
41,862
-20,967
| -33% | -$1.4M | 0.03% | 386 |
|
|
2015
Q2 | $6.11M | Buy |
+62,829
| New | +$6.11M | 0.08% | 268 |
|
|
2014
Q4 | – | Sell |
-22,452
| Closed | -$1.55M | – | 1080 |
|
|
2014
Q3 | $1.55M | Buy |
22,452
+12,591
| +128% | +$870K | 0.02% | 488 |
|
|
2014
Q2 | $566K | Buy |
+9,861
| New | +$566K | 0.01% | 585 |
|